600332.SH
白云山
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 20.11
−3.83%Margins
Gross margin
16.2%
EBITDA margin
5.6%
EBIT margin
4.6%
Net margin
3.8%
FCF margin
0.3%
7.4%
Return on equity
3.3%
Return on assets
6.4%
Return on invested capital
0.90x
Asset turnover
CNY 1.4B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026